47.73.Z - Retail sale of pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
70.22.Z - Head office activities and management consultancy
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
82.99.Z - Other business support activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1 | 1,5 | 0,5 | -65,3 |
EBITDA | 1 | 1,5 | 0,5 | -64,6 |
Short time liabilities | 0,4 | 0,4 | 0,4 | 10,6 |
Equity capital | 4,9 | 5,4 | 4,4 | -18,3 |
Operating profit (EBIT) | 1 | 1,5 | 0,5 | -65,3 |
Assets | 5,3 | 5,8 | 4,8 | -16,4 |
Net profit (loss) | 1 | 1,5 | 0,5 | -65,3 |
Cash | 0,3 | 0,2 | 0,2 | -17,6 |
Net income from sale | 6,5 | 10,5 | 7 | -33,1 |
Liabilities and provisions for liabilities | 0,4 | 0,4 | 0,4 | 10,6 |
Working assets | 5,1 | 5,7 | 4,7 | -17,6 |
Depreciation | 0 | 0 | 0 | 165,2 |
% | % | % | p.p. | |
Profitability of capital | 21,2 | 28 | 11,9 | -16,1 |
Equity capital to total assets | 92,5 | 93,7 | 91,6 | -2,1 |
Gross profit margin | 16,1 | 14,4 | 7,5 | -6,9 |
EBITDA Margin | 16,1 | 14,4 | 7,6 | -6,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 22 | 13 | 21 | 8 |
Current financial liquidity indicator | 12.926125526428223 | 15.679465293884277 | 11.682680130004883 | -4 |
Net dept to EBITDA | -0.2965395450592041 | -0.14353087544441223 | -0.3346412181854248 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane